Toggle Main Menu Toggle Search

Open Access padlockePrints

In vivo α-adrenergic responses and troponin I phosphorylation: Anesthesia interactions

Lookup NU author(s): Dr Guy MacGowanORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The mechanisms by which α-adrenergic stimulation of the heart in vivo can cause contractile dysfunction are not well understood. We hypothesized that α-adrenergic-mediated contractile dysfunction is mediated through protein kinase C phosphorylation of troponin I, which in in vitro experiments has been shown to reduce actomyosin Mg-ATPase activity. We studied pressure-volume loops in transgenic mice expressing mutant troponin I lacking protein kinase C phosphorylation sites and hypothesized altered responses to phenylephrine. As anesthesia agents can produce markedly different effects on contractility, we studied two agents: avertin and α-chloralose-urethane. With α-chloralose-urethane, at baseline, there were no contractile abnormalities in the troponin I mutants. Phenylephrine produced a 50% reduction in end-systolic elastance in wild-type controls, although a 9% increase in troponin I mutants (P < 0.05). Avertin was associated with reduced contractility compared with α-chloralose-urethane. Avertin anesthesia, at baseline, produced a reduction in end-systolic elastance by 31% in the troponin I mutants compared with wild-type (P < 0.05), and this resulted in further marked systolic and diastolic dysfunction with phenylephrine in the troponin I mutants. Dobutamine produced no significant difference in the contractile phenotype of the transgenic mice with either anesthetic regimen. In conclusion, these data (α-chloralose-urethane) demonstrate that α-adrenergic- mediated force reduction is mediated through troponin I protein kinase C phosphorylation. β-Adrenergic responses are not mediated through this pathway. Altering the myofilament force-calcium relationship may result in in vivo increased sensitivity to negative inotropy. Thus choice of a negative inotropic anesthetic agent (avertin) with phenylephrine can lead to profound contractile dysfunction. Copyright © 2005 the American Physiological Society.

Publication metadata

Author(s): MacGowan GA, Rager J, Shroff SG, Mathier MA

Publication type: Article

Publication status: Published

Journal: Journal of Applied Physiology

Year: 2005

Volume: 98

Issue: 4

Pages: 1163-1170

ISSN (print): 8750-7587

ISSN (electronic): 1522-1601

Publisher: American Physiological Society


DOI: 10.1152/japplphysiol.00959.2004

PubMed id: 15579573


Altmetrics provided by Altmetric


Funder referenceFunder name